New insights into antibiotic resistance
30 May 2022
Treatment of severe infections caused by pathogenic bacteria relies on ‘last resort’ antibiotics, but rising resistance by ‘superbugs’ to most clinically approved drugs leaves patients exposed to possible fatalities. Researchers are focusing on how bacterial cells adapt and resist antimicrobial medications — with a new article focusing on a hospital strain of Acinetobacter baumannii and its cellular response to important antibiotic colistin.
Further reading: Science Daily
Author(s): Science Daily
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
